treatment of early oligoarticular psoriatic arthritis with apremilast: the foremost trial
Published 10 hours ago • No plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
5:01
efficacy and safety of selective tyk2 inhibitor, deucravacitinib, trial in psoriatic arthritis
-
5:25
secukinumab in patients with psoriatic arthritis and axial manifestations
-
22:28
update in treatment of psoriatic arthritis
-
5:14
efficacy and safety of guselkumab in patients with active psoriatic arthritis
-
1:00:31
the diagnosis and management of psoriatic arthritis
-
2:30
psoriatic arthritis - 3d medical animation
-
55:47
expert panel: plaque psoriasis. the unmet need and scinai innovative treatment solution
-
13:51
psoriatic arthritis new treatment 2024
-
23:02
current therapies for psoriasis and psoriatic arthritis
-
59:33
3/3/2023: the road to prevention of psoriatic arthritis
-
50:56
the need for continued medical innovation in psoriatic arthritis
-
35:49
psoriatic arthritis: exploring a mechanistic approach to treatment
-
41:02
addressing disease progression in psoriatic arthritis: optimizing targeted therapies
-
7:58
otezla® (apremilast) mechanism of action in the treatment of psoriatic arthritis
-
7:28
treatment of psoriasis - new small molecules
-
2:27
prevention of psoriatic arthritis
-
5:59
standard of care and guidelines for psoriasis
-
2:07
april armstrong, md, mph - how do you manage the diarrhea associated with apremilast?